[1] The Human Evidence Gap and Where Research Is Heading The most intellectually honest statement about BPC-157 is this: an unusually robust preclinical literature has established a plausible and broadly consistent mechanistic picture, while the human clinical trial evidence remains essentially absent
The cation used according to the present invention does not influence the activity of the BPC peptides, but increases their stability
In contrast to PDGF-BB, in diabetic wounds, induced by alloxan application, BPC 157 largely promoted mature collagen in granulation tissue (Seveljevic-Jaran et al., 2006) (note, previously, BPC 157 healed alloxan-induced gastric lesions in rats (Petek et al., 1999))
Within 48 hours after injection of 100 or 1,000 mcg of Vitamin B12, 50 to 98% of the injected dose may appear in the urine
A comparative evaluation of the effectiveness of an anorganic bone matrix/cell binding peptide with an open flap debridement in human infrabony defects: a clinical and radiographic study